Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy

David Wang; Christopher Leo; Liping Liu; Li Huang; Lisa Huang; Yun Lu

doi:10.1136/svn-2023-002321

Open Access

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy

David Wang, Christopher Leo, Liping Liu, Li Huang, Lisa Huang, Yun Lu

DOI: 10.1136/svn-2023-002321 Published 25 August 2023

David Wang

1 Department of Neurology, Petznick Stroke Center, Barrow Neurological Institute, Phoenix, Arizona, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christopher Leo

2 Department of Medicine/Division of General Internal Medicine/Hospital Medicine, Duke University, Durham, North Carolina, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Liping Liu

3 Neurosurgical Intensive Care Unit (NICU), Beijing Tiantan Hospital, Capital Medical University, Beijing, China

4 China National Clinical Research Center for Neurological Diseases, Beijing, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Li Huang

5 Doctors Medical Center, Modesto, California, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lisa Huang

6 Chesapeake Regional Medical Center, Chesapeake, Virginia, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yun Lu

7 Hennepin Healthcare System and the University of Minnesota, Minneapolis, Minnesota, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
eLetters
Info & Metrics
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

No eLetters have been published for this article.

PreviousNext

Vol 8 Issue 4 Table of Contents

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Front Matter (PDF)

Thank you for your interest in spreading the word on Stroke and Vascular Neurology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy

Message Subject (Your Name) has sent you a message from Stroke and Vascular Neurology

Message Body (Your Name) thought you would like to see the Stroke and Vascular Neurology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Alerts

User Name *

Password *

Email *

Citation Tools

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy

David Wang, Christopher Leo, Liping Liu, Li Huang, Lisa Huang, Yun Lu

Stroke and Vascular Neurology Aug 2023, 8 (4) 263-265; DOI: 10.1136/svn-2023-002321

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite This

APA
Chicago
Endnote
MLA

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy

David Wang, Christopher Leo, Liping Liu, Li Huang, Lisa Huang, Yun Lu

Stroke and Vascular Neurology Aug 2023, 8 (4) 263-265; DOI: 10.1136/svn-2023-002321

Download PDF

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy

David Wang, Christopher Leo, Liping Liu, Li Huang, Lisa Huang, Yun Lu

Stroke and Vascular Neurology Aug 2023, 8 (4) 263-265; DOI: 10.1136/svn-2023-002321

Share This Article:

Respond to this article

Tweet Widget
Facebook Like
Google Plus One

Article
Figures & Data
eLetters
Info & Metrics
PDF

Main menu

User menu

Search

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy

Plain text

Vertical Tabs

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

CONTENT

JOURNAL

AUTHORS

HELP